Susanne Feinaeugle

Title: Susanne Feinaeugle: Innovator in Transdermal Therapeutic Systems

Introduction

Susanne Feinaeugle is a notable inventor based in Holzkirchen, Germany. She has made significant contributions to the field of transdermal therapeutic systems, particularly through her innovative work involving buprenorphine. Her dedication to advancing medical technology has led to the development of a unique system that enhances drug delivery.

Latest Patents

Feinaeugle holds a patent for a transdermal therapeutic system comprising buprenorphine. This invention focuses on a method of manufacturing a transdermal therapeutic system (TTS) that allows for the effective transdermal administration of buprenorphine and its analogues. The system is particularly designed for analgesic purposes, providing a new avenue for pain management. The TTS includes a drug delivery composition that combines buprenorphine with an adhesive component, which is a mixture of crosslinked and non-crosslinked acrylic polymers, along with a penetration enhancer that comprises a keto acid. She has 1 patent to her name.

Career Highlights

Feinaeugle is associated with Hexal AG, a company known for its focus on pharmaceutical innovations. Her work at Hexal AG has allowed her to collaborate with other talented professionals in the field, contributing to advancements in therapeutic systems.

Collaborations

Some of her notable coworkers include Jens Fleschhut and Karin Lauer. Their collaborative efforts have further enhanced the research and development of innovative therapeutic solutions.

Conclusion

Susanne Feinaeugle's contributions to the field of transdermal therapeutic systems exemplify her commitment to innovation in medicine. Her work continues to impact pain management strategies, showcasing the importance of research and development in healthcare.